Yandex N.V. (NASDAQ:YNDX) was rising 7.66% to $34.70 at 1:37 p.m. on Tuesday as the Russian Internet company, which operates the largest search engine in the country, rebounded from Monday’s heavy losses on the heels of Russia’s invasion of the Ukranian region of Crimea. Yandex NV (NASDAQ:YNDX) stock opened at $35.07 in last session, and closed at $34.31, while the day range of Yandex NV (NASDAQ:YNDX) stock is $33.85 – $35.30. The stock showed a positive weekly performance of -5.22%.
VIVUS, Inc. (NASDAQ:VVUS) on Feb. 24 provided a business update and reported its financial results for the fourth quarter and year ended December 31, 2013. For the fourth quarter of 2013, total net product revenue was $9.2 million, of which $7.7 million was from sales of Qsymia and the remaining amount was from STENDRA and SPEDRA. VIVUS, Inc. (NASDAQ:VVUS) stock opened at $6.23 in last session, and closed at $6.16 by gaining 1.15%. The 52 week range of $5.63 – $15.62. Company’s market capitalization is $630.65 million.
Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) on Mar. 4 announced that it has been notified by the U.S. Food and Drug Administration (the “FDA”) that the agency has completed its review of the September 2013 nonclinical submission and has lifted the clinical hold on Oxycyte®. Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) stock increased 14.52% and finished the last session at $7.10. The EPS of the stock remained -34.51. Company’s market capitalization is $35.09 million.
Analysts at RBC Capital initiated coverage on shares of WebMD Health Corp. in a research note on Thursday, February 13th. They set a “top pick” rating and a $70.00 price target on the stock. WebMD Health Corp. (NASDAQ:WBMD) stock opened the session at $41.60, and closed the session at $43.98. The 52 week range of the WebMD Health Corp. (NASDAQ:WBMD) stock remained $22.23 – $51.41 and the day range was $41.24 – $44.74.